Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2008, Vol. 28 Issue (5): 12-16    DOI:
    
The empirical study of indoleamine 2,3-dioxygenase in contributing to the immune escape on hepatoma carcinoma cell
Download: HTML   PDF(2570KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

This study was aimed to investigate the mechanism of indoleamine 2,3-dioxygenase(IDO) in HepG2 cells contributing to tumor immune escape. Methods T-lymphocyte and HepG2 cell were cocultured, and 1-methyl-tryptophan(1-MT) was added to make an intervening experiment. The expression of IDO mRNA in HepG2 cell cocultured with T-lymphocyte was detected by RT-PCR ;the apoptosis rate of HepG2 cell cocultured with T-lymphocyte was analyzed by flow cytometer; The cytotoxicity of T-lymphocyte against HepG2 cell was examined by MTT assay. Results In combine reaction system , the expression of IDO mRNA was strongly induced in HepG2 cell cocultured with T-lymphocyte and faintly induced when cultured with 1-MT ; the earlier apoptosis rate of HepG2 cell in control group and experiment group(1-MT:1.25 mmol/l,2.5 mmol/l,5mmol/l) was respectively(3.48±0.34)%,(7.82±0.41)%,(18.62±0.42)%,(25.32±0.40)%(P<0.01),The cytotoxicity of T-lymphocyte against HepG2 cell was respectively(17.36±1.24)%,(25.48±1.48)%,(32.89±1.73)%,(42.04±2.16)%(P<0.01). Conclusion These results suggest that IDO from HepG2 cell can suppress the tumor immunity of T-lymphocyte to kill hepatoma carcinoma cell, which may be contributing to hepatoma immune escape



Received: 29 December 2007      Published: 25 May 2008
Cite this article:

. The empirical study of indoleamine 2,3-dioxygenase in contributing to the immune escape on hepatoma carcinoma cell. China Biotechnology, 2008, 28(5): 12-16.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2008/V28/I5/12

No related articles found!